Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

574 ARTÍCULOS , VIENDO DEL 121 AL 135

Nutraceuticals-based therapeutic approach: recent advances to combat pathogenesis of Alzheimer's disease

Talebi M, Kakouri E, Talebi M, Tarantilis PA, Farkhondeh T, İlgün S, Pourbagher-Shahri AM, Samarghandian S.

Expert Rev Neurother. 2021 Jun;21(6):625-642. doi: 10.1080/14737175.2021.1923479. Epub 2021 May 16.

Potential therapeutic natural products against Alzheimer's disease with Reference of Acetylcholinesterase

Ahmed S, Khan ST, Zargaham MK, Khan AU, Khan S, Hussain A, Uddin J, Khan A, Al-Harrasi A.

Biomed Pharmacother. 2021 Jul;139:111609. doi: 10.1016/j.biopha.2021.111609. Epub 2021 May 4.

Advances in developing therapeutic strategies for Alzheimer's disease

Nguyen TT, Nguyen TTD, Nguyen TKO, Vo TK, Vo VG.

Biomed Pharmacother. 2021 Jul;139:111623. doi: 10.1016/j.biopha.2021.111623. Epub 2021 Apr 26.

Neuroprotective Herbs for the Management of Alzheimer's Disease

Gregory J, Vengalasetti YV, Bredesen DE, Rao RV.

Biomolecules. 2021 Apr 8;11(4):543. doi: 10.3390/biom11040543.

A Comprehensive Analysis into the Therapeutic Application of Natural Products as SIRT6 Modulators in Alzheimer's Disease, Aging, Cancer, Inflammation, and Diabetes

Akter R, Afrose A, Rahman MR, Chowdhury R, Nirzhor SSR, Khan RI, Kabir MT.

Int J Mol Sci. 2021 Apr 17;22(8):4180. doi: 10.3390/ijms22084180.

Resveratrol, Metabolic Dysregulation, and Alzheimer's Disease: Considerations for Neurogenerative Disease

Yang AJT, Bagit A, MacPherson REK.

Int J Mol Sci. 2021 Apr 28;22(9):4628. doi: 10.3390/ijms22094628.

Anti-Alzheimer's Molecules Derived from Marine Life: Understanding Molecular Mechanisms and Therapeutic Potential

Kabir MT, Uddin MS, Jeandet P, Emran TB, Mitra S, Albadrani GM, Sayed AA, Abdel-Daim MM, Simal-Gandara J.

Mar Drugs. 2021 Apr 28;19(5):251. doi: 10.3390/md19050251.

The Clinician's Interview-Based Impression of Change (Plus caregiver input) and goal attainment in two dementia drug trials: Clinical meaningfulness and the initial treatment response

Stanley J, Howlett SE, Dunn T, Rockwood K.

Alzheimers Dement. 2021 May;17(5):856-865. doi: 10.1002/alz.12242. Epub 2021 Apr 29.

A Review of the Application of Hyperbaric Oxygen Therapy in Alzheimer's Disease

Somaa F.

J Alzheimers Dis. 2021;81(4):1361-1367. doi: 10.3233/JAD-210157.

Phosphorylated tau targeted small-molecule PROTACs for the treatment of Alzheimer's disease and tauopathies

Jangampalli Adi P, Reddy PH.

Biochim Biophys Acta Mol Basis Dis. 2021 Aug 1;1867(8):166162. doi: 10.1016/j.bbadis.2021.166162. Epub 2021 Apr 30.

Meta-Analysis of Methamphetamine Modulation on Amyloid Precursor Protein through HMGB1 in Alzheimer's Disease

Alabed S, Zhou H, Sariyer IK, Chang SL.

Int J Mol Sci. 2021 Apr 30;22(9):4781. doi: 10.3390/ijms22094781.

Alzheimer's Disease-Rationales for Potential Treatment with the Thrombin Inhibitor Dabigatran

Grossmann K.

Int J Mol Sci. 2021 Apr 30;22(9):4805. doi: 10.3390/ijms22094805.

Progress with Treatments for Alzheimer's Disease

Levey AI.

N Engl J Med. 2021 May 6;384(18):1762-1763. doi: 10.1056/NEJMe2103722.

Neurocognitive effects of melatonin treatment in healthy adults and individuals with Alzheimer's disease and insomnia: A systematic review and meta-analysis of randomized controlled trials

Sumsuzzman DM, Choi J, Jin Y, Hong Y.

Neurosci Biobehav Rev. 2021 Aug;127:459-473. doi: 10.1016/j.neubiorev.2021.04.034. Epub 2021 May 3.

Feasibility of reducing frailty components in older adults with Alzheimer's dementia: a randomized controlled home-based exercise trial (AD-HOMEX)

Cezar NOC, Aprahamian I, Ansai JH, de Oliveira MPB, da Silva DCP, Gomes WL, Barreiros BA, Langelli TCO, de Andrade LP.

Exp Gerontol. 2021 Jul 15;150:111390. doi: 10.1016/j.exger.2021.111390. Epub 2021 May 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias